Representative Matters

Advised a participating investor on a Hong Kong financing round for a leading AI company, including due diligence, transaction structuring and execution.

Led the structuring of a Hong Kong investment platform for an RMB International Investment and Loan Fund, including cross-border structuring and regulatory analysis.

Advised on the use of onshore capital for investment in an RMB International Investment and Loan Fund and on related PRC outbound-investment compliance.

Advised on the formation of an offshore US dollar-denominated fund, including fund structuring and drafting the principal fund documents.

Advised a state-owned venture capital enterprise on the formation of an industrial M&A fund and conducted due diligence on a leading private equity manager.

Conducted a legal review of a proposed cooperation arrangement between a Shenzhen district-level industry guidance fund and an offshore fund manager.

Issued legal opinions for a state-owned venture capital enterprise in connection with a sci-tech innovation corporate bond offering on the Shenzhen Stock Exchange.

Led policy analysis, compliance assessment and implementation coordination for a UK semiconductor company's investment in China.

Provided legal and policy support for major Shenzhen projects in the display technology, semiconductor and life sciences sectors.

Contributed to policy research for the Qianhai Shenzhen-Hong Kong Modern Service Industry Cooperation Zone and to Shenzhen's plans and supporting policies for strategic emerging and future industries.

Assessed US export-control exposure for an investment by a Shenzhen institution and advised on material regulatory risks and mitigation measures.

Coordinated legal support for the establishment of a Shenzhen manufacturing base by a Singapore semiconductor testing company.

Advised an LCD panel manufacturer throughout the establishment of a manufacturing operation in Vietnam, including investment structuring, entity establishment and operational compliance.

Advised a wear-resistant materials company on the development of a manufacturing operation in Malaysia, including investment structuring, local compliance and implementation.

Coordinated legal advice for an aged-care and healthcare group on an investment in Australia.

Advised a leading Chinese pharmaceutical company on the acquisition of European rare-disease pipeline assets, including transaction structuring, due diligence and cross-border execution.

Advised a Hong Kong-listed biopharmaceutical company on an investment in a mainland China biopharmaceutical project, including transaction and implementation matters.

Advised on a transaction with an Israeli healthcare fund, including structuring, due diligence and compliance analysis.

Issued legal opinions for an Anhui provincial state-owned enterprise in connection with the disposal of an offshore real estate project.

Coordinated cross-border legal advice for a Shandong company following an investment fraud incident in Kazakhstan.

Advised a state-owned advanced-materials company on issues arising from a debtor's entry into Russian bankruptcy proceedings.

Advised on the recognition and enforcement of a CIETAC arbitral award in the United States.